Back to Trials
NCT05493722EARLY_PHASE1Recruiting

Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy

University of Minnesota

Start Date

9/15/2023

Completion Date

1/15/2030

Summary

Deep brain stimulation (DBS) is used to treat epilepsy in cases where patients are medically refractory and are not candidates for surgical resection. This therapy has been shown to be effective in seizure reduction, yet very few patients achieve the ultimate goal of seizure freedom. Implantable neural stimulators (INSs) have many parameters that may be adjusted, and could be tuned to achieve very patient specific therapies. This study will develop a platform for stimulation setting optimization based on power spectral density (PSD) measures.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * medically refractory epilepsy * already have a deep brain stimulator in place Exclusion Criteria: * severe dementia at investigator discretion

Interventions

OTHER

PS and OS stimulation order 1

OTHER

PS and OS stimulation order 2

OTHER

PS and OS stimulation order 3

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Refractory EpilepsyDeep Brain Stimulation

Locations

University of Minnesota

Minneapolis, Minnesota 55455

United States